Analytics brings together experts from claims, underwriting, risk management, legal, and Information Technology to conduct a comprehensive review of your MLMIC claims experience – identifying liability trends and potential exposures.
You’ll also receive a detailed analysis from a MLMIC Risk Management Consultant, resulting in a MLMIC Analytics Report. Follow-up sessions then help guide you through the report, with recommendations and assessments intended to reduce professional liability risks and increase patient safety, outcomes, and quality of care.
This service is offered exclusively to MLMIC policyholders.
To learn more about MLMIC Analytics contact a MLMIC representative.
Or, check out these other MLMIC exclusives:
Call 1-800-ASK-MLMIC or arrange a future call at a time convenient for you.
Download an application.
To address the shortage of Bacillus Calmette-Guerin (BCG) Live, a drug used in treatment of bladder cancer, the New York State Department of Health (NYSDOH) has issued interim infection control guidance permitting providers to treat multiple patients from the same single-use vial of BCG.